These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 1737390)
1. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390 [TBL] [Abstract][Full Text] [Related]
2. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938 [TBL] [Abstract][Full Text] [Related]
3. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells. Stanwell C; Gescher A; Bradshaw TD; Pettit GR Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895 [TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells. Dale IL; Bradshaw TD; Gescher A; Pettit GR Cancer Res; 1989 Jun; 49(12):3242-5. PubMed ID: 2720677 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway. Jalava A; Akerman K; Heikkilä J J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723 [TBL] [Abstract][Full Text] [Related]
6. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity. Levine BL; May WS; Tyler PG; Hess AD J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742 [TBL] [Abstract][Full Text] [Related]
7. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells. Scala S; Dickstein B; Regis J; Szallasi Z; Blumberg PM; Bates SE Clin Cancer Res; 1995 Dec; 1(12):1581-7. PubMed ID: 9815959 [TBL] [Abstract][Full Text] [Related]
8. Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Johnson MD; Torri JA; Lippman ME; Dickson RB Exp Cell Res; 1999 Feb; 247(1):105-13. PubMed ID: 10047452 [TBL] [Abstract][Full Text] [Related]
9. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis. Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972 [TBL] [Abstract][Full Text] [Related]
10. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1. Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857 [TBL] [Abstract][Full Text] [Related]
11. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha. Gschwend JE; Fair WR; Powell CT Mol Pharmacol; 2000 Jun; 57(6):1224-34. PubMed ID: 10825394 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of MCF-7 cell growth by 12-O-tetradecanoylphorbol-13-acetate and 1,2-dioctanoyl-sn-glycerol: distinct effects on protein kinase C activity. Issandou M; Bayard F; Darbon JM Cancer Res; 1988 Dec; 48(23):6943-50. PubMed ID: 3180102 [TBL] [Abstract][Full Text] [Related]
13. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity. Arita Y; Buffolino P; Coppock DL Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525 [TBL] [Abstract][Full Text] [Related]
14. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells. Boorne AJ; Donnelly N; Schrey MP Breast Cancer Res Treat; 1998 Mar; 48(2):117-24. PubMed ID: 9596483 [TBL] [Abstract][Full Text] [Related]
16. Growth of human melanocyte cultures supported by 12-O-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation. Arita Y; O'Driscoll KR; Weinstein IB Cancer Res; 1992 Aug; 52(16):4514-21. PubMed ID: 1643643 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C. Isakov N; Galron D; Mustelin T; Pettit GR; Altman A J Immunol; 1993 Feb; 150(4):1195-204. PubMed ID: 8432975 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines. Koga M; Musgrove EA; Sutherland RL Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149 [TBL] [Abstract][Full Text] [Related]
19. The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha. Clarke H; Ginanni N; Laughlin KV; Smith JB; Pettit GR; Mullin JM Exp Cell Res; 2000 Nov; 261(1):239-49. PubMed ID: 11082294 [TBL] [Abstract][Full Text] [Related]
20. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1. Basu A; Lazo JS Cancer Res; 1992 Jun; 52(11):3119-24. PubMed ID: 1591725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]